Becton Dickinson Stock - Sunday background on the medical technology group

Becton Dickinson stock gets a Sunday background treatment, with a look at its role in global medical devices, its diversified business segments and where the shares currently trade on the New York Stock Exchange.

Edited by ad hoc news Background & Management Desk. Verified prior to publication on 06/21/2026, 07:10 CET. Details in the imprint.

Becton Dickinson (US0718131099) is one of the world’s best-known medical technology companies, supplying devices and consumables across hospitals, laboratories and clinics. On Sunday the focus is on background and management rather than a specific market-moving headline from the past day.

How Becton Dickinson is structured

Becton, Dickinson and Company divides its business into three main segments: BD Medical, BD Life Sciences and BD Interventional, each with distinct end markets and product families.

According to the company’s latest annual report, BD Medical remains the largest segment by revenue, supplying syringes, insulin delivery devices, intravenous catheters and related systems used daily in hospitals and outpatient care.

Management, scale and global reach

BD’s headquarters are located in Franklin Lakes, New Jersey, and the group employs more than 70,000 people worldwide, underscoring its role as a major supplier across healthcare systems.

The company reports that it sells products in nearly 200 countries and territories, with manufacturing sites distributed across North America, Europe, Latin America and Asia to serve local demand and mitigate supply chain risks.

The business behind the stock

BD Medical focuses on medication delivery and management technologies, including hypodermic needles, prefillable syringes, infusion sets and infusion pumps for hospitals, ambulatory centers and home care.

BD Life Sciences provides diagnostic systems and reagents for specimen collection, microbiology, molecular diagnostics and oncology applications, serving clinical laboratories, blood banks and research institutions.

What the company sells

One representative product line is BD Vacutainer, a family of venous blood collection tubes and associated needles widely used for diagnostic blood draws in hospitals and laboratories around the world.

Where the stock trades today

The shares of Becton Dickinson (US0718131099) trade on the New York Stock Exchange under the ticker BDX, recently quoted around the low 200-dollar range in USD on 06/21/2026, 07:10 CET.

Key facts on Becton Dickinson stock

• Company: Becton, Dickinson and Company
• ISIN: US0718131099
• WKN: 857289
• Ticker: BDX
• Venue: NYSE
• Price (as of 06/21/2026, 07:10 CET): around 200 USD
• Market cap: in the several tens of billions of USD (as of 06/21/2026)
• Sector / Industry: Health Care / Medical Devices
• Index membership: S&P 500
• Next earnings date: not officially scheduled

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.